Screener
Summit Therapeutics SMMT Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's invested capital?
- Summit Therapeutics (SMMT) reported invested capital of $557.73M in Q1 2026.
- How has Summit Therapeutics's invested capital changed year-over-year?
- Summit Therapeutics's invested capital increased by 62.6% year-over-year, from $343.1M to $557.73M.
- What is the long-term trend for Summit Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Summit Therapeutics's invested capital has grown at a 117.9% compound annual growth rate (CAGR), from $13.5M to $663.38M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Summit Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude